NCI Community Oncology Research Program - Kansas City (NCORP-KC)
NCI Community Oncology Research Program - Kansas City (NCORP-KC)




NCI Community Oncology Research Program - Protocol Summary

ECOG-ACRIN EAQ162CD - "Longitudinal Assessment of Financial Burden in Patients with Colon or Rectal Cancer Treated with Curative Intent"

The summary below serves as a brief review of the treatment plan and eligibility for the protocol.


This summary is not intended to be used in place of the full eligibility & treatment information in the protocol.
 

Please contact NCORP-KC for complete protocol information.



Print This Summary

CCDR Clinical Trial

CANCER TYPE: GI
RESEARCH BASE: ECOG-ACRIN
NCT NUMBER: NCT03516942
HIPPA FORM: DOWNLOAD HIPPA FORM

Consent Form: VIEW CONSENT FORM
UPDATED ON 08/16/2018 (18:43:19)

BRIEF DESCRIPTION

Colorectal Ca, stage I, II, III, fill out questionnaires at 3,6,12,24 months regarding financial stress and quality of life.  DCP-001 Eligible.



NOTES


Baseline questionnaires:

  • Baseline Questionnaire
  • Baseline Employment
  • FACT-G7
  • Self-Efficacy
  • COST
  • Impact of Cost
  • Access and Utilization of Financial Resources
  • Site Survey
  • Baseline Clinical Form

3 month questionnaires:

  • Sociodemographic Follow-up
  • COST
  • Impact of Cost
  • Access and Utilization of Financial Resources
  • Follow-up Clinical Form

6 month questionnaires:

  • Sociodemographic Follow-up
  • Follow-up Employment
  • FACT-G7
  • Self-Efficacy
  • COST
  • Impact of Cost
  • Access and Utilization of Financial Resources
  • Follow-up Clinical Form

12 month questionnaires:

  • Sociodemographic Follow-up
  • Follow-up Employment
  • FACT-G7
  • Self-Efficacy
  • COST
  • Impact of Cost
  • Access and Utilization of Financial Resources
  • Acceptability
  • Follow-up Clinical Form

24 month questionnaires:

  • Sociodemographic Follow-up
  • Follow-up Employment
  • FACT-G7
  • COST
  • Impact of Cost
  • Access and Utilization of Financial Resources
  • Follow-up Clinical Form
  • 24-month Follow-up Clinical Form
  • End of Study Clinical Form


ELIGIBILITY

  • Age ≥ 18 years.
  • Patients must have a life expectancy of ≥ 24 months
  • ECOG PS 0-3
  • Patients must have a newly diagnosed colon or rectal cancer (initial diagnosis, either a biopsy or curative surgery, whichever is most recent) within 60 days of registration and have not yet received radiation or chemotherapy.
  • Patients must have Stage I, II, or III disease at the time of enrollment and will be treated with curative-intent. This can be defined either clinically or pathologically if they have already undergone surgery. For staging of both colon and rectal cancer, the definition of stage I-III is based on the seventh edition (2010) or an updated version of the TNM staging system.
  • Patients are not eligible if they are already enrolled on a treatment clinical trial at the time of registration. They can remain on the study if they subsequently enroll on a treatment clinical trial during the study time period.
  • Patients who choose to not receive radiation and/or chemotherapy after a curative-intent surgery are eligible to participate.
  • Patients with a history of previous malignancy (except non-melanoma skin or cervical in-situ cancer) treated (with either surgery, chemotherapy, and/or radiation) within the last 3 years are not eligible because it is possible that their employment and burden due to cancer care may be impacted by their previous malignancy and therefore add heterogeneity to the study.
  • Patients must be able to complete questionnaires in English.
  • Patients must sign and give written informed consent in accordance with institutional and federal guidelines.





  © 2013-2018 All Rights Reserved. Privacy Policy | Terms & Conditions
NCI Community Oncology Research Program - Kansas City (NCORP-KC)
Questions? Call: +1-913-948-5588 | Contact Us
4121 W. 83rd St., Suite 259 Prairie Village, KS 66208 USA